Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc. - Current Ratioverified

DBTX

Price:

$4.91

Market Cap:

$123.37M

Decibel Therapeutics, Inc. (DBTX) is a clinical-stage biotechnology firm dedicated to pioneering innovative therapies for a range of hearing and balance impairments. Their research and development efforts are concentrated across three primary therapeutic avenues: 1. Gene Therapies for Congenital, Monogenic Hearing Loss: These programs aim to re-establish functional cellular activity within the cochlea, thereby counteracting hearing deficiencies stemming from single gene mutations. 2. Gene Therapies for Hair Cell Regeneration: This pipeline focuses on replenishing lost hair cells in the inner ear to alleviate acquired hearing and balance conditions. 3. Otoprotection Therapeutic: Currently in ...[Read more]

Industry

Biotechnology

IPO Date

2021-02-12

Stock Exchange

NASDAQ

Ticker

DBTX

The Current Ratio as of June 2026 (TTM) for Decibel Therapeutics, Inc. (DBTX) is 4.81

According to Decibel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.81. This represents a change of 10.79% compared to the average of 4.34 of the last 4 quarters.

Decibel Therapeutics, Inc. (DBTX) Historical Current Ratio (quarterly & annually)

How has DBTX Current Ratio performed in the past?

The mean historical Current Ratio of Decibel Therapeutics, Inc. over the last ten years is 5.39. The current 4.81 Current Ratio has changed 8.83% with respect to the historical average. Over the past ten years (40 quarters), DBTX's Current Ratio was at its highest in in the March 2021 quarter at 12.56. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

5.39

Median

4.81

Minimum

2.98

Maximum

7.99

Decibel Therapeutics, Inc. (DBTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Decibel Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 167.84%

Maximum Annual Current Ratio = 7.99

Minimum Annual Increase = -53.27%

Minimum Annual Current Ratio = 2.98

Quarterly (TTM)
Annual
YearCurrent RatioChange
20224.81-39.79%
20217.99167.84%
20202.98-15.96%
20193.55-53.27%

Decibel Therapeutics, Inc. (DBTX) Average Current Ratio

How has DBTX Current Ratio performed in the past?

The current Current Ratio of Decibel Therapeutics, Inc. (DBTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.26

5-year avg

5.39

10-year avg

5.39

Decibel Therapeutics, Inc. (DBTX) Current Ratio vs. Peers

How is DBTX’s Current Ratio compared to its peers?

Decibel Therapeutics, Inc.’s Current Ratio is greater than Paratek Pharmaceuticals, Inc. (3.66), less than Kinnate Biopharma Inc. (13.19), less than Tourmaline Bio, Inc. (24.68), less than aTyr Pharma, Inc. (5.78), greater than Graybug Vision, Inc. (1.61), less than NGM Biopharmaceuticals, Inc. (7.79), less than Pardes Biosciences, Inc. (9.81), less than Selecta Biosciences, Inc. (7.65), greater than Sesen Bio, Inc. (0.86), less than Jounce Therapeutics, Inc. (8.37),

Build a custom stock screener for Decibel Therapeutics, Inc. (DBTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Decibel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Decibel Therapeutics, Inc. (DBTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Decibel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Decibel Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for Decibel Therapeutics, Inc. (DBTX)?

What is the highest Current Ratio for Decibel Therapeutics, Inc. (DBTX)?

What is the 3-year average Current Ratio for Decibel Therapeutics, Inc. (DBTX)?

What is the 5-year average Current Ratio for Decibel Therapeutics, Inc. (DBTX)?

How does the current Current Ratio for Decibel Therapeutics, Inc. (DBTX) compare to its historical average?